Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
AstraZeneca
McKinsey
Boehringer Ingelheim
Fuji
Farmers Insurance
McKesson
UBS
Daiichi Sankyo

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019081

« Back to Dashboard

NDA 019081 describes ESTRADERM, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the ESTRADERM profile page.

The generic ingredient in ESTRADERM is estradiol. There are seventy-five drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Summary for 019081
Tradename:ESTRADERM
Applicant:Novartis
Ingredient:estradiol
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019081

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.05MG/24HR
Approval Date:Sep 10, 1986TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.1MG/24HR
Approval Date:Sep 10, 1986TE:RLD:Yes

Expired US Patents for NDA 019081

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis ESTRADERM estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 019081-002 Sep 10, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis ESTRADERM estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 019081-003 Sep 10, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis ESTRADERM estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 019081-003 Sep 10, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis ESTRADERM estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 019081-002 Sep 10, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Harvard Business School
Mallinckrodt
Colorcon
Fish and Richardson
QuintilesIMS
Farmers Insurance
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.